Page last updated: 2024-10-23

bendroflumethiazide and Stevens-Johnson Syndrome

bendroflumethiazide has been researched along with Stevens-Johnson Syndrome in 1 studies

Bendroflumethiazide: A thiazide diuretic with actions and uses similar to those of HYDROCHLOROTHIAZIDE. It has been used in the treatment of familial hyperkalemia, hypertension, edema, and urinary tract disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p810)
bendroflumethiazide : A sulfonamide consisting of 7-sulfamoyl-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide in which the hydrogen at position 6 is substituted by a trifluoromethyl group and that at position 3 is substituted by a benzyl group.

Stevens-Johnson Syndrome: Rare cutaneous eruption characterized by extensive KERATINOCYTE apoptosis resulting in skin detachment with mucosal involvement. It is often provoked by the use of drugs (e.g., antibiotics and anticonvulsants) or associated with PNEUMONIA, MYCOPLASMA. It is considered a continuum of Toxic Epidermal Necrolysis.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Caldwell, IW1
Montgomery, PR1
Peachey, RD1

Other Studies

1 other study available for bendroflumethiazide and Stevens-Johnson Syndrome

ArticleYear
Toxic epidermal necrolysis and malignant lymphoma.
    The British journal of dermatology, 1967, Volume: 79, Issue:5

    Topics: Adult; Aged; Bendroflumethiazide; Chloramphenicol; Cyclizine; Female; Hodgkin Disease; Humans; Lymph

1967